100,912 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by abrdn plc

abrdn plc purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 100,912 shares of the company’s stock, valued at approximately $7,847,000. abrdn plc owned about 0.11% of Acadia Healthcare as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of ACHC. Vanguard Group Inc. raised its holdings in Acadia Healthcare by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 8,831,131 shares of the company’s stock valued at $620,917,000 after acquiring an additional 26,379 shares during the last quarter. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after acquiring an additional 152,783 shares during the last quarter. William Blair Investment Management LLC raised its holdings in Acadia Healthcare by 0.3% in the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock valued at $215,072,000 after acquiring an additional 10,062 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Acadia Healthcare by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock valued at $88,482,000 after acquiring an additional 13,765 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Acadia Healthcare by 4.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 996,704 shares of the company’s stock valued at $70,078,000 after acquiring an additional 38,664 shares during the last quarter.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $73.59 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The stock has a market capitalization of $6.80 billion, a P/E ratio of -294.35, a PEG ratio of 2.10 and a beta of 1.31. The company has a 50 day moving average price of $78.07 and a 200 day moving average price of $77.66. Acadia Healthcare Company, Inc. has a fifty-two week low of $66.49 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The firm had revenue of $742.80 million during the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company posted $0.70 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective for the company in a report on Thursday. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Stephens upgraded shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a report on Friday, January 5th. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Mizuho raised their price target on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, March 6th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $92.00.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.